The West Midlands is fast becoming one of the UK’s most important hubs for life sciences and data-driven healthcare innovation. With a £10.3 billion healthcare and life sciences economy, the region offers a vibrant, supportive environment for research, commercialisation, and real-world clinical impact.
A thriving life sciences ecosystem
The region boasts more than 600 life sciences and healthcare businesses, alongside 80 hospitals, 35 clinical research centres and eight NHS trusts. The region has one of the UK’s highest concentrations of clinical trial activity activity led by the University of Birmingham’s Cancer Research UK Clinical Trials Unit and Birmingham Clinical Trials Unit, while Birmingham Women’s and Children’s NHS Foundation Trust is host to the new £7m NIHR Central and North West Midlands Commercial Research Delivery Centre. This enhanced focus on commercial clinical trials has also led to the establishment of the Industry Trials Hub at the Precision Health Technologies Accelerator (PHTA), which will shortly open its doors as part of No.1 Birmingham Health Innovation Campus.
Professor Gino Martini, CEO of PHTA, explained: “The Industry Trials Hub links academic excellence and disease-specific clinical expertise from across Birmingham’s health and life sciences district with innovations from industry, to deliver patient-relevant clinical trials that can directly contribute to market authorisation. This gives our industry partners a more rapid pathway to clinical adoption – which is great news for patients and great for the UK life sciences sector too.
“It’s important that this is taking place in Birmingham as it is a ‘world within a city’ – representing the global population in terms of its ethnic profile and socioeconomic demographics. Our Hub will therefore be able to recruit ethnically-diverse representation in the majority of its clinical trials which has the potential to benefit patients all over the world.”
Its diverse and stable population of 4.7 million provides a significant advantage for businesses working on genomics, personalised medicine, and data-led diagnostics. This is further strengthened by the presence of PIONEER and INSIGHT – two of the UK’s Health Data Research UK hubs.
A location for growth and talent
The West Midlands is home to five top-tier universities, four medical schools, and over 87,000 STEM students, producing 11,000 medical science graduates annually. Companies in the region can access this future-ready workforce while benefiting from a 30-40% cost saving on property and skills compared to London.
David Kidney, Chair, West Midlands Health Technology Cluster commented “The West Midlands is a region where ideas don’t just stay in the lab – they become real solutions that improve lives. Our unique blend of academic excellence, clinical capacity, and advanced manufacturing makes us one of the most exciting places in the UK – and Europe – to build and grow health technology businesses.”
The future is digital and data-driven
The region is leading the way in Digital Health, supported by one of the UK’s largest 5G testbeds, deep AI and immersive tech capabilities, and robust health data integration. Add to this its strength in advanced manufacturing and MedTech – a £1.7 billion economy – and the West Midlands becomes a one-stop destination for innovation from bench to bedside.As the host of Life Sciences Week, the West Midlands invites investors, innovators and entrepreneurs to discover the opportunities that await in a region designed to help you thrive.
